🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

307,02 USD

Máx. histórico

322,75

3 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-4,87%

Rango 52 semanas

175,89 – 326,63

Variación hoy

-4,87%

Cierre anterior

322,75

Rango de hoy

306,17 – 324,95

Volumen hoy

265.433

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
32,35 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 1 día
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/02/1993 36,49 38,37 36,49 36,49 -1,27% 5,13% 1.095
08/02/1993 39,30 39,30 36,49 36,96 -3,66% 7,14% 6.786
05/02/1993 37,43 40,24 36,49 38,37 -4,65% 10,00% 20.331
04/02/1993 37,43 40,24 37,43 40,24 +0,00% 7,50% 1.790
03/02/1993 37,43 40,24 37,43 40,24 +7,50% 7,50% 588
02/02/1993 40,24 40,24 37,43 37,43 -6,98% 6,98% 4.515
01/02/1993 40,24 40,24 37,43 40,24 +0,00% 6,98% 5.130
29/01/1993 40,24 40,24 37,43 40,24 +0,00% 6,98% 1.790
28/01/1993 40,24 40,24 38,37 40,24 +0,00% 4,65% 7.187
27/01/1993 41,17 41,17 38,37 40,24 +1,18% 6,82% 4.382
26/01/1993 43,04 43,04 38,37 39,77 -3,41% 10,87% 14.053
25/01/1993 41,17 43,98 39,30 41,17 +15,79% 11,36% 62.517
22/01/1993 35,56 35,56 32,75 35,56 +8,57% 7,89% 9.164
21/01/1993 35,56 35,56 32,75 32,75 -4,11% 7,89% 29.041
20/01/1993 32,75 35,56 32,75 34,15 -3,95% 8,57% 4.462
19/01/1993 38,37 40,24 32,75 35,56 -11,63% 19,51% 16.164
18/01/1993 40,24 40,24 37,43 40,24 +0,00% 6,98% 4.435
15/01/1993 40,24 40,24 37,43 40,24 +4,88% 6,98% 802
14/01/1993 39,30 40,24 37,43 38,37 -4,65% 7,14% 5.611
13/01/1993 39,77 40,24 38,37 40,24 -2,27% 4,71% 347
12/01/1993 39,30 41,17 38,37 41,17 +0,00% 7,14% 2.191
11/01/1993 39,30 41,17 36,49 41,17 +4,76% 11,90% 3.767
08/01/1993 40,24 41,17 36,49 39,30 +0,00% 11,63% 12.851
07/01/1993 39,30 42,11 39,30 39,30 -2,33% 7,14% 1.603
06/01/1993 40,24 42,11 39,30 40,24 -4,44% 6,98% 9.297
05/01/1993 45,85 45,85 41,17 42,11 -8,16% 10,20% 21.480
04/01/1993 39,30 45,85 39,30 45,85 +16,67% 16,67% 9.324
31/12/1992 37,43 40,24 35,56 39,30 -2,33% 12,50% 39.915
30/12/1992 37,43 40,24 37,43 40,24 +7,50% 7,50% 6.412
29/12/1992 37,43 40,24 37,43 37,43 +0,00% 7,50% 2.405